The Genome Clinic: A Multidisciplinary Approach to Assessing the Opportunities and Challenges of Integrating Genomic Analysis into Clinical Care

Human Mutation

Volumn 35, Issue 5, 2014, Pages 513-519

  Bowdin, Sarah ^a,b   Ray, Peter N ^a,c   Cohn, Ronald D ^a,b,c   Meyn, M Stephen ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Ethical concerns; Health policy; Incidental findings; Next generation sequencing

Indexed keywords

ALLELE; ARTICLE; BIOINFORMATICS; CLINICAL ASSESSMENT; CLINICAL PRACTICE; DNA REPAIR; EMPLOYMENT; ENDOPHENOTYPE; ETHICIST; FOLLOW UP; GENE DELETION; GENETIC COUNSELING; GENETIC SCREENING; GENOME ANALYSIS; HAPLOINSUFFICIENCY; HEALTH CARE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH ECONOMICS; HEALTH INSURANCE; HUMAN; INFORMED CONSENT; MICROARRAY ANALYSIS; PATHOGENICITY; PATIENT CARE; PATIENT PREFERENCE; PERSONALIZED MEDICINE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGICAL ASPECT; RISK BENEFIT ANALYSIS; BIOLOGY; ECONOMICS; GENETIC VARIABILITY; GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN GENOME; MEDICAL RESEARCH; PROCEDURES;

BIOMEDICAL RESEARCH; COMPUTATIONAL BIOLOGY; GENETIC TESTING; GENETIC VARIATION; GENOME, HUMAN; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INDIVIDUALIZED MEDICINE;

EID: 84898832381     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22536     Document Type: Article

References (41)

1. American Academy of Pediatrics Committee on Bioethics. 2010. Policy statement-children as hematopoietric stem cell donors. Pediatrics 125:392-404.
2. Bean LJ, Tinker SW, da Silva C, Hegde MR. 2013. Free the data: one laboratory's approach to knowledge-based genomic variant classification and preparation for EMR integration of genomic data. Hum Mutat 34:1183-1188.
3. Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, Langley RJ, Zhang L, Lee CC, Schilkey FD, Sheth V, Woodward JE, et al. 2011. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 3:65ra4.
4. Berg JS, Adams M, Nassar N, Bizon C, Lee K, Schmitt CP, Wilhelmsen KC, Evans JP. 2013. An informatics approach to analyzing the incidentalome. Genet Med 15:36-44.
5. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. 2002. Penetrance of 845G-> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359:211-218.
6. Biesecker LG, Mullikin JC, Facio FM, Turner C, Cherukuri PF, Blakesley RW, Bouffard GG, Chines PS, Cruz P, Hansen NF, Teer JK, Maskeri B, et al. 2009. The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine. Genome Res 19:1665-1674.
7. Borry P, Stultiens L, Nys H, Cassiman JJ, Dierickx K. 2006. Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clin Genet 70:374-381.
8. Botkin JR, Teutsch SM, Kaye CI, Hayes M, Haddow JE, Bradley LA, Szegda K, Dotson WD. 2010. Outcomes of interest in evidence-based evaluations of genetic tests. Genet Med 12:228-235.
9. Burke W, Matheny Antommaria AH, Bennett R, Botkin J, Clayton EW, Henderson GE, Holm IA, Jarvik GP, Khoury MJ, Knoppers BM, Press NA, Ross LF, et al. 2013. Recommendations for returning genomic incidental findings? We need to talk! Genet Med 15:854-859.
10. Cassa CA, Tong MY, Jordan DM. 2013. Large numbers of genetic variants considered to be pathogenic are common in asymptomatic individuals. Hum Mutat 34:1216-1220.
11. Dorey E. 2013. Newborns sequenced at NIH. Nat Biotech 31:948.
12. Dorschner MO, Amendola LM, Turner EH, Robertson PD, Shirts BH, Gallego CJ, Bennett RL, Jones KL, Tokita MJ, Bennett JT, Kim JH, Rosenthal EA, et al. 2013. Actionable, pathogenic incidental findings in 1, 000 participants' exomes. Am J Hum Genet 93:631-640.
13. Facio FM, Eidem H, Fisher T, Brooks S, Linn A, Kaphingst KA, Biesecker LG, Biesecker BB. 2013. Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study. Eur J Hum Genet 21:261-265.
14. Fiume M, Smith EJ, Brook A, Strbenac D, Turner B, Melzini AM, Robinson MD, Wodak SJ, Brudno M. 2012. Savant Genome Browser 2: visualization and analysis for population-scale genomics. Nucleic Acids Res 40:W615-W621.
15. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, et al. 1998. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676-689.
16. Foster MW, Mulvihill JJ, Sharp RR. 2009. Evaluating the utility of personal genomic information. Genet Med 11:570-574.
17. Frank M, Prenzler A, Eils R, von der Schulenburg J-MG. 2013. Genome sequencing: a systematic review of health economic evidence. Health Econ Rev 3:29-36.
18. Genetic Information Nondiscrimination Act of 2008. (PL 110-233, May 21, 2008). United States Statutes at Large 122:881-922.
19. Girdea M, Dumitriu S, Fiume M, Bowdin S, Boycott KM, Chenier S, Chitayat D, Faghfoury H, Meyn MS, Ray PN, So J, Stavropoulos DJ, et al. 2013. PhenoTips: patient phenotyping software for clinical and research use. Hum Mutat 34:1057-1065.
20. Gray VE, Kukurba KR, Kumar S. 2012. Performance of computational tools in evaluating the functional impact of laboratory-induced amino acid mutations. Bioinformatics 28:2093-2096.
21. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, et al. 2013. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 15:565-574.
22. Grosse SD, Kalman L, Khoury MJ. 2010. Evaluation of the validity and utility of genetic testing for rare diseases. Adv Exp Med Biol 686:115-131.
23. Jacob HJ, Abrams K, Bick DP, Brodie K, Dimmock DP, Farrell M, Geurts J, Harris J, Helbling D, Joers BJ, Kliegman R, Kowalski G, et al. 2013. Genomics in clinical practice: lessons from the front lines. Sci Transl Med 5:194cm5.
24. Jiang YH, Yuen RK, Jin X, Wang M, Chen N, Wu X, Ju J, Mei J, Shi Y, He M, Wang G, Liang J, et al. 2013. Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am J Hum Genet 93:249-263.
25. Johnston JJ, Rubinstein WS, Facio FM, Ng D, Singh LN, Teer JK, Mullikin JC, Biesecker LG. 2012. Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. Am J Hum Genet 91:97-108.
26. Lemke A, Bick D, Dimmock D, Simpson P, Veith R. 2013. Perspectives of clinical genetics professionals toward genome sequencing and incidental findings: a survey study. Clin Genet 84:230-236.
27. Lewis A, James P. 2012. An incidental finding of a large genomic deletion of BRCA1 in a molecular karyotype for a 5 year old child. Hered Cancer Clin Pract 10:A73.
28. Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M. 2010. Genetic susceptibility to breast cancer. Mol Oncol 4:174-191.
29. Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, Evans DG, Izatt L, Eeles RA, Adlard J, Davidson R, Eccles D, et al. 2013. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 105:812-822.
30. McGuire AL, Joffe S, Koenig BA, Biesecker BB, McCullough LB, Blumenthal-Barby JS, Caulfield T, Terry SF, Green RC. 2013. Point-counterpoint. Ethics and genomic incidental findings. Science 340:1047-1048.
31. O'Rawe J, Jiang T, Sun G, Wu Y, Wang W, Hu J, Bodily P, Tian L, Hakonarson H, Johnson WE, Wei Z, Wang K, et al. 2013. Low concordance of multiple variant-calling pipelines: practical implications for exome and genome sequencing. Genome Med 5:28.
32. Rasmussen LJ, Heinen CD, Royer-Pokora B, Drost M, Tavtigian S, Hofstra RM, de Wind N. 2012. Pathological assessment of mismatch repair gene variants in Lynch syndrome: past, present, and future. Hum Mutat 33:1617-1625.
33. Saukko PM, Ellard S, Richards SH, Shepherd MH, Campbell JL. 2007. Patients' understanding of genetic susceptibility testing in mainstream medicine: qualitative study on thrombophilia. BMC Health Serv Res 7:82.
34. Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. 2012. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res 40(Web Server issue):W452-W457.
35. Solomon BD, Nguyen AD, Bear KA, Wolfsberg TG. 2013. Clinical genomic database. Proc Natl Acad Sci USA 110:9851-9855.
36. Szego M, Meyn MS, Anderson J, Hayeems R, Shuman C, Monfared N, Bowdin S, Zlotnik-Shaul R. 2014. Predictive genomic testing of children for adult onset disorders: a Canadian perspective. Am J Bioethics 14:19-21.
37. Tong MY, Cassa CA, Kohane IS. 2011. Automated validation of genetic variants from large databases: ensuring that variant references refer to the same genomic locations. Bioinformatics 27:891-893.
38. Veenstra DL, Piper M, Haddow JE, Pauker SG, Klein R, Richards CS, Tunis SR, Djulbegovic B, Marrone M, Lin JS, Berg AO, Calonge N. 2013. Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update. Genet Med 15:14-24.
39. Walker S, Scherer SW. 2013. Identification of candidate intergenic risk loci in autism spectrum disorder. BMC Genomics 14:499-505.
40. Wolf SM. 2013. Return of individual research results and incidental findings: facing the challenges of translational science. Annu Rev Genomics Hum Genet 14:557-577.
41. Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, Braxton A, Beuten J, Xia F, Niu Z, Hardison M, Person R, et al. 2013. Clinical whole-exome sequencing for the diagnosis of Mendelian disorders. N Engl J Med 369:1502-1511.